株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

米国における電気生理検査装置市場の見通し

United States Electrophysiology Market Outlook to 2020

発行 GlobalData 商品コード 301450
出版日 ページ情報 英文 118 Pages
即納可能
価格
本日の銀行送金レート: 1USD=114.71円で換算しております。
Back to Top
米国における電気生理検査装置市場の見通し United States Electrophysiology Market Outlook to 2020
出版日: 2014年05月05日 ページ情報: 英文 118 Pages
概要

当レポートでは、米国における電気生理検査装置市場について、診断用カテーテル、アブレーション用カテーテル、検査システムのカテゴリー別売上、販売数の実績および予測、平均価格、企業シェア、流通シェア、主要企業のプロファイル、パイプライン製品、主な財務取引についての最新情報などを提供しまとめており、概略以下の構成でお届けします。

第1章 目次

第2章 イントロダクション

  • レポートの内容
  • 電気生理検査市場の区分
  • 本レポートで対象としている市場の定義

第3章 米国における電気生理検査装置市場

  • 収益(実績)
  • 収益(予測)
  • 販売数(実績)
  • 販売数(予測)
  • 平均価格
  • 流通シェア:収益別
  • 企業シェア:収益別

第4章 主要企業の概要

  • Biosense Webster, Inc.
  • St. Jude Medical, Inc.
  • C. R. Bard, Inc.
  • Boston Scientific Corporation
  • Medtronic, Inc.
  • Biotronik SE & Co. KG

第5章 パイプライン製品

第6章 財務取引の情勢

  • 買収
  • 社債発行
  • 提携
  • ベンチャー資金調達

第7章 最近の動向

  • コーポレート・コミュニケーション
  • 財務発表
  • 政府および公益関連
  • 法規制
  • その他重要な動向
  • 製品情報
  • 戦略および事業企画

第8章 付録

図表

目次
Product Code: GDMECC0336DB

GlobalData's new report, "United States Electrophysiology Market Outlook to 2020", provides key market data on the United States Electrophysiology market. The report provides value, in millions of US dollars, and volume (in units) and average price data (in US dollars), within market categories - Electrophysiology Diagnostic Catheters, Electrophysiology Ablation Catheters and Electrophysiology Lab Systems.

The report also provides company shares and distribution shares data for the market category, and global corporate-level profiles of the key market participants, pipeline products, and news and deals related to the Electrophysiology market wherever available.

The data in the report is derived from dynamic market forecast models. GlobalData uses epidemiology and capital equipment-based models to estimate and forecast the market size. The objective is to provide information that represents the most up-to-date data of the industry possible.

The epidemiology-based forecasting model makes use of epidemiology data gathered from research publications and primary interviews with physicians to establish the target patient population and treatment flow patterns for individual diseases and therapies. Using prevalence and incidence data and diagnosed and treated population, the epidemiology-based forecasting model arrives at the final numbers.

Capital equipment-based forecasting models are done based on the installed base, replacements and new sales of a specific device/equipment in healthcare facilities such as hospitals, clinics and diagnostic centers. Data for average number of units per facility is used to arrive at the installed base of the capital equipment. Sales for a particular year are arrived at by calculating the replacement units and new units (additional and first-time purchases).

Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the market size, company share and distribution share data and analysis.

Scope

  • Market size for Electrophysiology Devices categories - Electrophysiology Diagnostic Catheters, Electrophysiology Ablation Catheters and Electrophysiology Lab Systems.
  • Annualized market revenue (USD million), volume (units) and average selling price ($) data for the market categories. Data is provided from 2005 to 2012 and forecast to 2020.
  • 2012 company shares and distribution shares data for the market category.
  • Global corporate-level profiles of key companies operating within the United States Electrophysiology market.
  • Key players covered include Biosense Webster, Inc., St. Jude Medical, Inc., C.R. Bard, Inc., Boston Scientific Corporation, Medtronic, Inc. and BIOTRONIK SE & Co. KG.

Reasons to buy

  • Develop business strategies by identifying the key market categories and segments poised for strong growth in the future.
  • Develop market-entry and market expansion strategies.
  • Design competition strategies by identifying who-stands-where in the market.
  • Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.
  • What are the key distribution channels and what's the most preferred mode of product distribution - Identify, understand and capitalize.

Table of Contents

1. Table of Contents

  • 1.1. List of Tables
  • 1.2. List of Figures

2. Introduction

  • 2.1. What Is This Report About?
  • 2.2. Electrophysiology Market Segmentation
  • 2.3. Definitions of Markets Covered in the Report

3. Electrophysiology Market, United States

  • 3.1. Electrophysiology Market, United States, Revenue ($m), 2005-2012
  • 3.2. Electrophysiology Market, United States, Revenue ($m), 2012-2020
    • 3.2.1. Electrophysiology Ablation Catheters Market, United States, Revenue ($m), by Segment, 2005-2012
    • 3.2.2. Electrophysiology Diagnostic Catheters Market, United States, Revenue ($m), by Segment, 2005-2012
    • 3.2.3. Electrophysiology Ablation Catheters Market, United States, Revenue ($m), by Segment, 2012-2020
    • 3.2.4. Electrophysiology Diagnostic Catheters Market, United States, Revenue ($m), by Segment, 2012-2020
  • 3.3. Electrophysiology Market, United States, Volume (Units), 2005-2012
  • 3.4. Electrophysiology Market, United States, Volume (Units), 2012-2020
    • 3.4.1. Electrophysiology Ablation Catheters Market, United States, Volume (Units), by Segment, 2005-2012
    • 3.4.2. Electrophysiology Diagnostic Catheters Market, United States, Volume (Units), by Segment, 2005-2012
    • 3.4.3. Electrophysiology Ablation Catheters Market, United States, Volume (Units), by Segment, 2012-2020
    • 3.4.4. Electrophysiology Diagnostic Catheters Market, United States, Volume (Units), by Segment, 2012-2020
  • 3.5. Electrophysiology Market, United States, Average Price ($), 2005-2020
  • 3.6. Electrophysiology Market, United States, Distribution Share by Revenue ($m), 2011-2012
  • 3.7. Electrophysiology Market, United States, Company Share by Revenue ($m), 2011-2012

4. Overview of Key Companies in United States, Electrophysiology Market

  • 4.1. Biosense Webster, Inc.
    • 4.1.1. Company Overview
  • 4.2. St. Jude Medical, Inc.
    • 4.2.1. Company Overview
  • 4.3. C. R. Bard, Inc.
    • 4.3.1. Company Overview
  • 4.4. Boston Scientific Corporation
    • 4.4.1. Company Overview
  • 4.5. Medtronic, Inc.
    • 4.5.1. Company Overview
  • 4.6. Biotronik SE & Co. KG
    • 4.6.1. Company Overview

5. Electrophysiology Market Pipeline Products

6. Financial Deals Landscape

  • 6.1. Acquisition
    • 6.1.1. Vanguard Acquires 6.7% Stake In Boston Scientific
    • 6.1.2. Fidelity Acquires 10.5% Stake In Boston Scientific, Medical Device Company
    • 6.1.3. Boston Scientific Completes Acquisition of Bard Electrophysiology From C. R. Bard For US$275 Million
    • 6.1.4. Merit Medical Completes Acquisition Of Thomas Medical From GE Healthcare For Up To US$167 Million
    • 6.1.5. Boston Scientific Completes Acquisition Of Rhythmia Medical, Cardiac Arrhythmia Device Maker, For Up To US$265 Million
  • 6.2. Debt Offerings
    • 6.2.1. Boston Scientific Completes Public Offering Of Notes Due 2023 For US$450 Million
    • 6.2.2. Boston Scientific Completes Public Offering Of Notes Due 2018 For US$600 Million
    • 6.2.3. St. Jude Medical Completes Public Offering Of Notes Due 2023 For US$900 Million
    • 6.2.4. St. Jude Medical Completes Public Offering Of Notes Due 2043 For US$700 Million
  • 6.3. Partnerships
    • 6.3.1. Philips Enters Into Technology Integration Agreement With Biosense Webster
    • 6.3.2. Biosense Webster Enters Into Technology Integration Agreement With GE Healthcare Systems And Siemens Healthcare
  • 6.4. Venture Financing
    • 6.4.1. MC10 Raises US$20 Million In Venture Financing
    • 6.4.2. Acutus Medical Raises US$28 Million In Series B Financing
    • 6.4.3. Acutus Medical Raises US$2.5 Million In Venture Financing

7. Recent Developments

  • 7.1. Corporate Communications
    • 7.1.1. Mar 03, 2014: Boston Scientific Elects Edward J. Ludwig To Its Board Of Directors
    • 7.1.2. Feb 10, 2014: Hansen Medical Announces Appointment of Chris Lowe as Interim CEO; Bruce Barclay to Depart the Company
    • 7.1.3. Feb 10, 2014: Hansen Medical Appoints Chris Lowe as Interim CEO
    • 7.1.4. Jan 28, 2014: St. Jude Medical Announces Organizational and Executive Leadership Changes
    • 7.1.5. Jan 06, 2014: Boston Scientific Names Craig Thompson, M.D. As New Chief Medical Officer, Interventional Cardiology
    • 7.1.6. Dec 16, 2013: Deutsche Private Equity Completes Acquisition Of Zellbios, API Manufacturer
    • 7.1.7. Dec 16, 2013: Boston Scientific Elects David Roux To Its Board of Directors
    • 7.1.8. Nov 21, 2013: Susan Lisa Named Vice President Of Investor Relations Of Boston Scientific
    • 7.1.9. Oct 24, 2013: Boston Scientific Announces Transition Plan For New Chief Financial Officer
    • 7.1.10. Oct 22, 2013: Boston Scientific Eliminates 1500 Jobs
    • 7.1.11. Jul 22, 2013: St. Jude Medical Appoints Stefan Widensohler to Its Board of Directors
    • 7.1.12. Jul 17, 2013: Marjorie Bowen Appointed to Hansen Medical's Board of Directors
  • 7.2. Financial Announcements
    • 7.2.1. Apr 22, 2014: Bard Announces First Quarter Results
    • 7.2.2. Apr 16, 2014: St. Jude Medical Reports First Quarter 2014 Results
    • 7.2.3. Feb 20, 2014: Hansen Medical Reports Fourth Quarter and Full-Year 2013 Results
    • 7.2.4. Feb 04, 2014: Boston Scientific Announces Results For Fourth Quarter And Full Year Ended December 31, 2012
    • 7.2.5. Jan 30, 2014: Bard Announces Fourth Quarter Results
    • 7.2.6. Jan 22, 2014: St. Jude Medical Reports Fourth Quarter and Full-Year 2013 Results
    • 7.2.7. Jan 13, 2014: Hansen Medical Reports Preliminary Fourth Quarter and Full-Year 2013 Results and Recent Business Highlights
    • 7.2.8. Dec 11, 2013: Bard Declares Quarterly Dividend
    • 7.2.9. Dec 09, 2013: St. Jude Medical Announces Fourth Quarter Dividend
    • 7.2.10. Nov 06, 2013: Hansen Medical Reports Third Quarter and Nine-Month 2013 Results
    • 7.2.11. Oct 28, 2013: Hansen Medical Announces Third Quarter 2013 Results Conference Call
    • 7.2.12. Oct 24, 2013: Boston Scientific Announces Results For Third Quarter Ended September 30, 2013
    • 7.2.13. Oct 22, 2013: Bard Announces Third Quarter Results
    • 7.2.14. Oct 16, 2013: St. Jude Medical Reports Third Quarter 2013 Results
    • 7.2.15. Oct 10, 2013: Boston Scientific To Webcast Conference Call Discussing Third Quarter 2013 Financial Results On October 24
    • 7.2.16. Oct 09, 2013: Bard Declares Quarterly Dividend
    • 7.2.17. Oct 02, 2013: St. Jude Medical Announces Third Quarter 2013 Earnings Conference Call
    • 7.2.18. Oct 01, 2013: Bard to Host Earnings Conference Call on October 22, 2013
    • 7.2.19. Aug 07, 2013: Hansen Medical Reports Second Quarter and Six-Month 2013 Results
    • 7.2.20. Jul 30, 2013: St. Jude Medical Announces Third Quarter Dividend
    • 7.2.21. Jul 25, 2013: Boston Scientific Announces Results For Second Quarter Ended June 30, 2013
    • 7.2.22. Jul 24, 2013: Bard Announces Second Quarter Results
    • 7.2.23. Jul 23, 2013: Hansen Medical Reports Preliminary Second Quarter 2013 Results
    • 7.2.24. Jul 17, 2013: St. Jude Medical Reports Second Quarter 2013 Results
    • 7.2.25. Jul 02, 2013: St. Jude Medical Announces Second Quarter 2013 Earnings Conference Call
    • 7.2.26. May 08, 2013: Hansen Reports Revenue Of $3m In Q1 2013
    • 7.2.27. May 01, 2013: St. Jude Medical Announces Second Quarter Dividend
  • 7.3. Government and Public Interest
    • 7.3.1. Jan 08, 2014: Hansen Medical to Present at the 32nd Annual J.P. Morgan Healthcare Conference
    • 7.3.2. Jan 06, 2014: Bard to Host Earnings Conference Call on January 30, 2014
    • 7.3.3. Jan 02, 2014: Boston Scientific To Participate In 32nd Annual J.P. Morgan Healthcare Conference
    • 7.3.4. Jan 02, 2014: Boston Scientific To Participate In 32nd Annual J.P. Morgan Healthcare Conference
    • 7.3.5. Dec 20, 2013: Bard to Present at J.P. Morgan Healthcare Conference
    • 7.3.6. Dec 18, 2013: St. Jude Medical to Present at the 32nd Annual J.P. Morgan Healthcare Conference
    • 7.3.7. Nov 25, 2013: Hansen Medical to Present at 25th Annual Piper Jaffray Healthcare Conference
    • 7.3.8. Nov 22, 2013: Boston Scientific To Participate In 25th Annual Piper Jaffray Healthcare Conference
    • 7.3.9. Nov 21, 2013: St. Jude Medical to Present at the Piper Jaffray 25th Annual Healthcare Conference
    • 7.3.10. Nov 20, 2013: Bard to Present at Piper Jaffray Healthcare Conference
    • 7.3.11. Nov 11, 2013: Hansen Medical to Present at Barclays Select Series 2013: Select Growth Conference
    • 7.3.12. Nov 06, 2013: St. Jude Medical to Present at the 2013 Credit Suisse Healthcare Conference
    • 7.3.13. Nov 01, 2013: St. Jude Medical to Present at the 2013 Credit Suisse Healthcare Conference
    • 7.3.14. Oct 31, 2013: Boston Scientific To Participate In 2013 Credit Suisse Healthcare Conference
    • 7.3.15. Oct 29, 2013: Bard to Present at Credit Suisse Healthcare Conference
    • 7.3.16. Sep 04, 2013: Boston Scientific To Participate In 2013 Stifel Nicolaus Healthcare Conference
    • 7.3.17. Sep 04, 2013: St. Jude Medical to Present at the Stifel Healthcare Conference
    • 7.3.18. Sep 03, 2013: St. Jude Medical to Present at the Morgan Stanley Global Healthcare Conference
    • 7.3.19. Sep 03, 2013: Bard to Host Conference Call on September 4, 2013
    • 7.3.20. Aug 20, 2013: Bard to Present at Morgan Stanley Global Healthcare Conference
  • 7.4. Legal And Regulatory
    • 7.4.1. Sep 17, 2013: OrbusNeich, Boston Scientific Settle Patent Litigation
    • 7.4.2. May 08, 2013: Hansen Medical Announces Agreement In Principle To Settle Securities Class Action
  • 7.5. Other Significant Developments
    • 7.5.1. Apr 16, 2014: Bard Declares Quarterly Dividend
    • 7.5.2. Mar 19, 2014: Boston Scientific Receives Prestigious Shingo Award for Operational Excellence
    • 7.5.3. Feb 24, 2014: St. Jude Medical Announces Increase in Quarterly Dividend
    • 7.5.4. Jul 10, 2013: Hansen Medical to Replace Current Debt Facility With New $33 Million, Interest-Only Debt Facility Through 2017
    • 7.5.5. May 29, 2013: GE Healthcare Acquires Transactional Business Of Unisyn Medical Technologies
  • 7.6. Product News
    • 7.6.1. Mar 30, 2014: New Long-term Data Demonstrate Patients with Mild Heart Failure Sustained Lower Mortality Rates After Receiving Boston Scientific CRT Defibrillators
    • 7.6.2. Dec 27, 2013: Mymetics Enters Into Licensing Agreement With RSV For Respiratory Syncytial Virus Vaccine
    • 7.6.3. May 29, 2013: Hansen Medical Gets Conditional Approval For ARTISAN-AF Trial From FDA For Treatment Of Atrial Fibrillation
  • 7.7. Strategy And Business Planning
    • 7.7.1. Sep 17, 2013: Boston Scientific Opens Institute For Advancing Science, Innovation Center In Shanghai

8. Appendix

  • 8.1. Research Methodology
    • 8.1.1. Coverage
    • 8.1.2. Secondary Research
    • 8.1.3. Primary Research
    • 8.1.4. Market Modeling and Forecasting
    • 8.1.5. Company Share Analysis
    • 8.1.6. Distribution Share Analysis
  • 8.2. Expert Panel
  • 8.3. GlobalData Consulting
  • 8.4. Contact Us
  • 8.5. Disclaimer

List of Tables

  • Table 1: Electrophysiology Market, United States, Revenue ($m), USD Constant, Historic, 2005-2012
  • Table 2: Electrophysiology Market, United States, Revenue ($m), USD Constant, Forecast, 2012-2020
  • Table 3: Electrophysiology Ablation Catheters Market, United States, Revenue ($m), USD Constant, Historic, 2005-2012
  • Table 4: Electrophysiology Diagnostic Catheters Market, United States, Revenue ($m), USD Constant, Historic, 2005-2012
  • Table 5: Electrophysiology Ablation Catheters Market, United States, Revenue ($m), USD Constant, Forecast, 2012-2020
  • Table 6: Electrophysiology Diagnostic Catheters Market, United States, Revenue ($m), USD Constant, Forecast, 2012-2020
  • Table 7: Electrophysiology Market, United States, Volume (Units), Historic, 2005-2012
  • Table 8: Electrophysiology Market, United States, Volume (Units), Forecast, 2012-2020
  • Table 9: Electrophysiology Ablation Catheters Market, United States, Volume (Units), Historic, 2005-2012
  • Table 10: Electrophysiology Diagnostic Catheters Market, United States, Volume (Units), Historic, 2005-2012
  • Table 11: Electrophysiology Ablation Catheters Market, United States, Volume (Units), Forecast, 2012-2020
  • Table 12: Electrophysiology Diagnostic Catheters Market, United States, Volume (Units), Forecast, 2012-2020
  • Table 13: Electrophysiology Market, United States, Average Price ($), Historic, 2005-2012
  • Table 14: Electrophysiology Market, United States, Average Price ($), Forecast, 2012-2020
  • Table 15: Electrophysiology Market, United States, Distribution Share by Revenue ($m), USD Constant, 2011-2012
  • Table 16: Electrophysiology Market, United States, Company Share by Revenue ($m), USD Constant, 2011-2012
  • Table 17: Electrophysiology Market Pipeline Products
  • Table 18: Vanguard Acquires 6.7% Stake In Boston Scientific
  • Table 19: Fidelity Acquires 10.5% Stake In Boston Scientific, Medical Device Company
  • Table 20: Boston Scientific Completes Acquisition of Bard Electrophysiology From C. R. Bard For US$275 Million
  • Table 21: Merit Medical Completes Acquisition Of Thomas Medical From GE Healthcare For Up To US$167 Million
  • Table 22: Boston Scientific Completes Acquisition Of Rhythmia Medical, Cardiac Arrhythmia Device Maker, For Up To US$265 Million
  • Table 23: Boston Scientific Completes Public Offering Of Notes Due 2023 For US$450 Million
  • Table 24: Boston Scientific Completes Public Offering Of Notes Due 2018 For US$600 Million
  • Table 25: St. Jude Medical Completes Public Offering Of Notes Due 2023 For US$900 Million
  • Table 26: St. Jude Medical Completes Public Offering Of Notes Due 2043 For US$700 Million
  • Table 27: Philips Enters Into Technology Integration Agreement With Biosense Webster
  • Table 28: Biosense Webster Enters Into Technology Integration Agreement With GE Healthcare Systems And Siemens Healthcare
  • Table 29: MC10 Raises US$20 Million In Venture Financing
  • Table 30: Acutus Medical Raises US$28 Million In Series B Financing
  • Table 31: Acutus Medical Raises US$2.5 Million In Venture Financing
  • Table 32: Total Number of Primary Research Participants, Cardiovascular Devices Market, by Country

List of Figures

  • Figure 1: Electrophysiology Market, United States, Revenue ($m), USD Constant, Historic, 2005-2012
  • Figure 2: Electrophysiology Market, United States, Revenue ($m), USD Constant, Forecast, 2012-2020
  • Figure 3: Electrophysiology Ablation Catheters Market, United States, Revenue ($m), USD Constant, Historic, 2005-2012
  • Figure 4: Electrophysiology Diagnostic Catheters Market, United States, Revenue ($m), USD Constant, Historic, 2005-2012
  • Figure 5: Electrophysiology Ablation Catheters Market, United States, Revenue ($m), USD Constant, Forecast, 2012-2020
  • Figure 6: Electrophysiology Diagnostic Catheters Market, United States, Revenue ($m), USD Constant, Forecast, 2012-2020
  • Figure 7: Electrophysiology Market, United States, Volume (Units), Historic, 2005-2012
  • Figure 8: Electrophysiology Market, United States, Volume (Units), Forecast, 2012-2020
  • Figure 9: Electrophysiology Ablation Catheters Market, United States, Volume (Units), Historic, 2005-2012
  • Figure 10: Electrophysiology Diagnostic Catheters Market, United States, Volume (Units), Historic, 2005-2012
  • Figure 11: Electrophysiology Ablation Catheters Market, United States, Volume (Units), Forecast, 2012-2020
  • Figure 12: Electrophysiology Diagnostic Catheters Market, United States, Volume (Units), Forecast, 2012-2020
  • Figure 13: Electrophysiology Market, United States, Company Share (%), 2012
  • Figure 14: GlobalData Epidemiology-Based Forecasting Model
  • Figure 15: GlobalData Capital Equipment-Based Forecasting Model
  • Figure 16: Primary Interviews by Participant Type (%)
Back to Top